Authors:
LOWTHER N
TOMLINSON B
FOX R
FALLER B
SERGEJEW T
DONNELLY H
Citation: N. Lowther et al., CACO-2 CELL-PERMEABILITY OF A NEW (HYDROXYBENZYL)ETHYLENEDIAMINE ORALIRON CHELATOR - CORRELATION WITH PHYSICOCHEMICAL PROPERTIES AND ORAL ACTIVITY, Journal of pharmaceutical sciences, 87(9), 1998, pp. 1041-1045
Authors:
LAMEIRE N
VANBIESEN W
DOMBROS N
DRATWA M
FALLER B
GAHL GM
GOKAL R
KREDIET RT
LAGRECA G
MAIORCA R
MATTHYS E
RYCKELYNCK JP
SELGAS R
WALLS J
Citation: N. Lameire et al., THE REFERRAL PATTERN OF PATIENTS WITH ESRD IS A DETERMINANT IN THE CHOICE OF DIALYSIS MODALITY, Peritoneal dialysis international, 17, 1997, pp. 161-166
Authors:
LAFORET M
FROELICH N
PARISSIADIS A
PFEIFFER B
SCHELL A
FALLER B
WOEHLJAEGLE ML
CAZENAVE JP
TONGIO MM
Citation: M. Laforet et al., A NUCLEOTIDE INSERTION IN EXON-4 IS RESPONSIBLE FOR THE ABSENCE OF EXPRESSION OF AN HLA-A-ASTERISK-01 ALLELE, Tissue antigens, 50(4), 1997, pp. 347-350
Authors:
BENDING M
MELLOTTE G
HASHMI C
COLES GA
MORGAN JD
ASHMAN R
SCHURGERS ML
GORDIS BZ
DHOORE MM
FALLER B
GENESTIER S
GRAWEY I
SLINGENEYER A
LAROCHE B
VILLE JL
WINNEY RJ
PLANT WD
MILES RS
SCOUSE P
WILLIAMS P
MONCRIEFF N
BROWN C
NORMAN P
NICHOLS N
RENNES JG
HOLMES CJ
HUDSON I
HORTON D
Citation: M. Bending et al., NASAL MUPIROCIN PREVENTS STAPHYLOCOCCUS-AUREUS EXIT-SITE INFECTION DURING PERITONEAL-DIALYSIS, Journal of the American Society of Nephrology, 7(11), 1996, pp. 2403-2408
Authors:
FALLER B
SHOCKLEY T
GENESTIER S
GENTILE S
DEVOS C
BURKE R
TAMINNE M
FAICT D
GUIBERTEAU R
MARTIS L
Citation: B. Faller et al., A COMPARATIVE CLINICAL-STUDY OF PERITONEAL-DIALYSIS SOLUTIONS CONTAINING POLYGLUCOSE AND POLYGLUCOSE IN COMBINATION WITH AMINO-ACIDS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 510-510
Authors:
FALLER B
APARICIO M
FAICT D
DEVOS C
DEPRECIGOUT V
LARROUMET N
GUIBERTEAU R
JONES M
PELUSO F
Citation: B. Faller et al., CLINICAL-EVALUATION OF AN OPTIMIZED 1.1-PERCENT AMINO-ACID SOLUTION FOR PERITONEAL-DIALYSIS, Nephrology, dialysis, transplantation, 10(8), 1995, pp. 1432-1437
Authors:
GENESTIER S
HEDELIN G
SCHAFFER P
FALLER B
Citation: S. Genestier et al., PROGNOSTIC FACTORS IN CAPD PATIENTS - A RETROSPECTIVE STUDY OF A 10-YEAR PERIOD, Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1905-1911
Citation: B. Piraino et B. Faller, THE PREVENTION OF STAPHYLOCOCCUS-AUREUS PERITONEAL DIALYSIS-RELATED INFECTIONS, Seminars in dialysis, 8(6), 1995, pp. 355-358
Authors:
HELLSTERN P
MOBERG U
EKBLAD M
ANDER CU
FALLER B
MULLER S
Citation: P. Hellstern et al., IN-VITRO CHARACTERIZATION OF ANTITHROMBIN III CONCENTRATES - A SINGLE-BLIND STUDY, Haemostasis, 25(4), 1995, pp. 193-201
Citation: B. Faller et N. Lameire, EVOLUTION OF CLINICAL-PARAMETERS AND PERITONEAL FUNCTION IN A COHORT OF CAPD PATIENTS FOLLOWED OVER 7 YEARS, Nephrology, dialysis, transplantation, 9(3), 1994, pp. 280-286
Authors:
COLES GA
UTTLEY L
VENNEGOOR M
FALLER B
FERIANI M
CORONEL F
LINDHOLM B
CHENG I
OREOPOULOS D
PIRAINO B
GAGNON R
RIELLA M
Citation: Ga. Coles et al., RECOMMENDATIONS OF THE INTERNATIONAL SOCIETY FOR PERITONEAL-DIALYSIS FOR TRAINING REQUIREMENTS OF NEPHROLOGY TRAINEES AND NURSES, Peritoneal dialysis international, 14(2), 1994, pp. 117-120
Citation: B. Faller et H. Nick, KINETICS AND MECHANISM OF IRON(III) REMOVAL FROM CITRATE BY DESFERRIOXAMINE-B AND 3-HYDROXY-1,2-DIMETHYL-4-PYRIDONE, Journal of the American Chemical Society, 116(9), 1994, pp. 3860-3865
Authors:
FALLER B
SLINGENEYER A
WALLER M
MICHEL C
GRUTZMACHER P
MULLER HP
BARANY P
GRABENSEE B
ISSAD B
SCHMITT H
MEISL F
Citation: B. Faller et al., DAILY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN(RHEPO) IN PERITONEAL-DIALYSIS PATIENTS - A EUROPEAN DOSE-RESPONSE STUDY, Clinical nephrology, 40(3), 1993, pp. 168-175
Citation: B. Faller et al., DEMONSTRATION OF A 2-STEP REACTION-MECHANISM FOR THE INHIBITION OF HEPARIN-BOUND NEUTROPHIL ELASTASE BY ALPHA-1-PROTEINASE INHIBITOR, Biochemistry, 32(35), 1993, pp. 9230-9235